Carr, Lesley K. “Botulinum Toxin A Should Not Be First-Line Therapy for Overactivebladder”. Canadian Urological Association Journal 5, no. 3 (April 4, 2013): 204–9. Accessed October 2, 2023. https://cuaj.ca/index.php/journal/article/view/643.